| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 4.59e-05 | 9 | 174 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 4.59e-05 | 9 | 174 | 3 | GO:0008091 | |
| Domain | WD40 | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 2.61e-05 | 259 | 170 | 11 | PF00400 |
| Domain | CH | 2.76e-05 | 65 | 170 | 6 | SM00033 | |
| Domain | WD40 | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 3.57e-05 | 268 | 170 | 11 | SM00320 |
| Domain | WD40_repeat | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 4.09e-05 | 272 | 170 | 11 | IPR001680 |
| Domain | CH | 4.22e-05 | 70 | 170 | 6 | PF00307 | |
| Domain | - | 4.57e-05 | 71 | 170 | 6 | 1.10.418.10 | |
| Domain | WD_REPEATS_1 | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 4.98e-05 | 278 | 170 | 11 | PS00678 |
| Domain | ACTININ_2 | 5.13e-05 | 23 | 170 | 4 | PS00020 | |
| Domain | ACTININ_1 | 5.13e-05 | 23 | 170 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.13e-05 | 23 | 170 | 4 | IPR001589 | |
| Domain | WD_REPEATS_2 | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 5.14e-05 | 279 | 170 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 5.14e-05 | 279 | 170 | 11 | PS50294 |
| Domain | CH | 5.35e-05 | 73 | 170 | 6 | PS50021 | |
| Domain | PH_dom-spectrin-type | 5.98e-05 | 9 | 170 | 3 | IPR001605 | |
| Domain | CH-domain | 6.24e-05 | 75 | 170 | 6 | IPR001715 | |
| Domain | WD40_repeat_dom | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 9.00e-05 | 297 | 170 | 11 | IPR017986 |
| Domain | - | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 2.44e-04 | 333 | 170 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 2.57e-04 | 335 | 170 | 11 | IPR015943 |
| Domain | ARM-type_fold | SMG1 NBEAL1 RNPEPL1 DOCK9 RICTOR HEATR5A BTAF1 TRIP12 VIRMA RPTOR BRAT1 | 2.84e-04 | 339 | 170 | 11 | IPR016024 |
| Domain | N2O_reductase_N | 3.11e-04 | 15 | 170 | 3 | IPR011045 | |
| Domain | Spectrin_bsu | 4.88e-04 | 4 | 170 | 2 | IPR016343 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 EPPK1 ESYT1 POLE PIEZO1 RNPEPL1 DOCK9 NAGLU MYOM3 BTAF1 WRAP53 POM121C HDAC7 C2CD2 ST14 KIAA2013 FZR1 MDN1 PROM2 RPTOR CHD5 NLRC5 PLA2G6 CABIN1 BRAT1 MMP17 IQGAP3 TRAPPC9 | 2.32e-12 | 1105 | 176 | 28 | 35748872 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 RNGTT ESYT1 NOL6 RICTOR POM121C TRIP12 TRIP10 POM121 UBR5 AIFM1 SUPT6H NUFIP2 NXF1 PML | 8.39e-09 | 440 | 176 | 15 | 34244565 |
| Pubmed | ANK3 ESYT1 NEDD1 POM121C POM121 MEIOC NUFIP2 SECISBP2 PEAK1 PLEKHA7 | 1.04e-06 | 263 | 176 | 10 | 34702444 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DAGLB ESYT1 POLE BTAF1 POM121C TRIP12 KIAA2013 ARL6IP6 POM121 CEP78 UBR5 COG1 RPTOR NUFIP2 CSTF3 BRAT1 IQGAP3 QSOX2 | 1.58e-06 | 942 | 176 | 18 | 31073040 |
| Pubmed | TANC2 SMG1 POLE NOL6 ADCK2 PDCD7 POM121C VIRMA DNAH7 RHEB MDN1 GYS1 PHACTR3 PRDX5 | 5.14e-06 | 638 | 176 | 14 | 31182584 | |
| Pubmed | TANC2 KCNH7 ANK3 SCAMP1 DOCK9 SPTBN1 ATG2B RICTOR SHROOM2 RHEB NSFL1C AJM1 RPTOR NUFIP2 PRICKLE2 KNDC1 ASTN1 PEAK1 PRDX5 | 5.74e-06 | 1139 | 176 | 19 | 36417873 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ISYNA1 ANK3 ARHGAP23 ESYT1 DOCK9 SPTBN1 SPTBN2 GPRC5A NSFL1C PROM2 CLMN PEAK1 PLEKHA7 | 6.82e-06 | 565 | 176 | 13 | 25468996 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MBLAC2 ANK3 FOLH1 FBXL17 BTAF1 ADGRV1 NEDD1 SHROOM2 PLBD2 C2CD2 TTC19 PROM2 CLMN SUPT6H RPTOR KNDC1 NLRC5 CSTF3 PLA2G6 SPIDR TRAPPC9 TBL1X | 6.99e-06 | 1489 | 176 | 22 | 28611215 |
| Pubmed | Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. | 7.00e-06 | 8 | 176 | 3 | 17991864 | |
| Pubmed | TANC2 ARHGAP23 SPTBN2 RICTOR POM121C GALNT16 KIAA2013 MYO15B POM121 SPIDR PEAK1 TRAPPC9 | 8.89e-06 | 493 | 176 | 12 | 15368895 | |
| Pubmed | 1.37e-05 | 153 | 176 | 7 | 10718198 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.49e-05 | 10 | 176 | 3 | 22159418 | |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 15809305 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 POLE RPS8 NOL6 TRIP12 VIRMA TRIP10 UBR5 GYS1 FDXR PRPF39 IQGAP3 NXF1 LCMT1 | 1.55e-05 | 704 | 176 | 14 | 29955894 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.55e-05 | 104 | 176 | 6 | 31240132 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 2.04e-05 | 11 | 176 | 3 | 20427287 | |
| Pubmed | mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis. | 2.55e-05 | 2 | 176 | 2 | 26132202 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29767533 | ||
| Pubmed | Raptor directs Sertoli cell cytoskeletal organization and polarity in the mouse testis. | 2.55e-05 | 2 | 176 | 2 | 29961810 | |
| Pubmed | The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis. | 2.55e-05 | 2 | 176 | 2 | 28435016 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 38577917 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17071581 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 30988188 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16959881 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25582201 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 2.55e-05 | 2 | 176 | 2 | 26884715 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19443702 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32896617 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28679588 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25389371 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 22815285 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12167650 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16740475 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33482765 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33155352 | ||
| Pubmed | A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. | 2.55e-05 | 2 | 176 | 2 | 19376817 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17074766 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20399258 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32579474 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15946940 | ||
| Pubmed | Negative regulation of stress-induced matrix metalloproteinase-9 by Sirt1 in skin tissue. | 2.55e-05 | 2 | 176 | 2 | 20812964 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20679732 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25995453 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27729429 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18474440 | ||
| Pubmed | 2-Deoxy glucose regulate MMP-9 in a SIRT-1 dependent and NFkB independent mechanism. | 2.55e-05 | 2 | 176 | 2 | 27704463 | |
| Pubmed | mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation. | 2.55e-05 | 2 | 176 | 2 | 28945203 | |
| Pubmed | Expression of Raptor and Rictor and their relationships with angiogenesis in colorectal cancer. | 2.55e-05 | 2 | 176 | 2 | 32039630 | |
| Pubmed | Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus. | 2.55e-05 | 2 | 176 | 2 | 16651542 | |
| Pubmed | 3.51e-05 | 13 | 176 | 3 | 18796539 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ESYT1 SPTBN1 RICTOR TRIP12 VIRMA DNAH7 HDAC7 MDN1 CLMN RPTOR PEAK1 PLEKHA7 TRAPPC9 PML | 3.54e-05 | 861 | 176 | 15 | 36931259 |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 3.64e-05 | 178 | 176 | 7 | 27637333 | |
| Pubmed | ANK3 SPOPL SCAMP1 DOCK9 SPTBN1 RICTOR SHROOM2 TRIP12 DCAF5 CLMN AGA ASXL2 PEAK1 PLEKHA7 QSOX2 PML RAD17 | 3.96e-05 | 1084 | 176 | 17 | 11544199 | |
| Pubmed | A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. | 4.09e-05 | 38 | 176 | 4 | 38346162 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 IFT27 GALC RNGTT ANK3 ESYT1 ATG2B NEDD1 POM121C HDAC7 POM121 RPTOR GYS1 NUFIP2 PLEKHA7 IQGAP3 TRAPPC9 FOXJ1 WDR48 | 4.42e-05 | 1321 | 176 | 19 | 27173435 |
| Pubmed | 7.35e-05 | 44 | 176 | 4 | 26471122 | ||
| Pubmed | Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. | 7.61e-05 | 3 | 176 | 2 | 17620337 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 23440873 | ||
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 7.61e-05 | 3 | 176 | 2 | 25385646 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 28813526 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 7.61e-05 | 3 | 176 | 2 | 30802453 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 18597705 | ||
| Pubmed | Dendritic cell Piezo1 directs the differentiation of TH1 and Treg cells in cancer. | 7.61e-05 | 3 | 176 | 2 | 35993548 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 21358638 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 18463162 | ||
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 7.61e-05 | 3 | 176 | 2 | 20008564 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 34737104 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 35507432 | ||
| Pubmed | Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation. | 7.61e-05 | 3 | 176 | 2 | 23873758 | |
| Pubmed | Impact of Raptor and Rictor Deletion on Hippocampal Pathology Following Status Epilepticus. | 7.61e-05 | 3 | 176 | 2 | 35618880 | |
| Pubmed | Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. | 7.61e-05 | 3 | 176 | 2 | 12006491 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 24315998 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 23637229 | ||
| Pubmed | mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. | 7.61e-05 | 3 | 176 | 2 | 25893604 | |
| Pubmed | MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism. | 7.61e-05 | 3 | 176 | 2 | 28233301 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 33540799 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 19145465 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 28546423 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 21852229 | ||
| Pubmed | mTORC1 and mTORC2 differentially promote natural killer cell development. | 7.61e-05 | 3 | 176 | 2 | 29809146 | |
| Pubmed | Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. | 7.61e-05 | 3 | 176 | 2 | 17996922 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 32691156 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 26363527 | ||
| Pubmed | Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. | 7.61e-05 | 3 | 176 | 2 | 18625722 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 21471201 | ||
| Pubmed | The Potential Role of BRCA1-Associated ATM Activator-1 (BRAT1) in Regulation of mTOR. | 7.61e-05 | 3 | 176 | 2 | 25657994 | |
| Pubmed | Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course. | 7.61e-05 | 3 | 176 | 2 | 23898069 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 21810931 | ||
| Pubmed | Localization of Rheb to the endomembrane is critical for its signaling function. | 7.61e-05 | 3 | 176 | 2 | 16631613 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 22143799 | ||
| Pubmed | Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. | 7.61e-05 | 3 | 176 | 2 | 19724909 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 18614546 | ||
| Pubmed | Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death. | 7.61e-05 | 3 | 176 | 2 | 25032863 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 19046572 | ||
| Pubmed | Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). | 7.61e-05 | 3 | 176 | 2 | 21245319 | |
| Pubmed | Leptin Signaling Suppression in Macrophages Improves Immunometabolic Outcomes in Obesity. | 7.61e-05 | 3 | 176 | 2 | 35377454 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 24671993 | ||
| Pubmed | Lipolysis and the integrated physiology of lipid energy metabolism. | 7.61e-05 | 3 | 176 | 2 | 18762440 | |
| Pubmed | Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. | 7.61e-05 | 3 | 176 | 2 | 23212520 | |
| Pubmed | mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. | 7.61e-05 | 3 | 176 | 2 | 24958889 | |
| Interaction | TOP3B interactions | TANC2 EPPK1 ESYT1 POLE PIEZO1 RNPEPL1 DOCK9 SPTBN2 NAGLU MYOM3 BTAF1 WRAP53 NEDD1 POM121C HDAC7 C2CD2 ST14 KIAA2013 FZR1 MDN1 PROM2 RPTOR CHD5 NUFIP2 NLRC5 SECISBP2 PLA2G6 CABIN1 BRAT1 MMP17 IQGAP3 TRAPPC9 | 9.15e-07 | 1470 | 173 | 32 | int:TOP3B |
| GeneFamily | WD repeat domain containing | NBEAL1 EML6 PEX7 WRAP53 NEDD1 DCAF5 RFWD3 FZR1 RPTOR TBL1X WDR48 | 3.59e-07 | 262 | 105 | 11 | 362 |
| GeneFamily | EF-hand domain containing|Spectrins | 6.55e-06 | 7 | 105 | 3 | 1113 | |
| GeneFamily | Components of oligomeric golgi complex | 9.14e-04 | 8 | 105 | 2 | 493 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.28e-03 | 206 | 105 | 6 | 682 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 ANK3 FBXL17 ADGRV1 PRICKLE2 SPIDR PEAK1 PLEKHA7 TRAPPC9 | 9.47e-08 | 198 | 175 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-06 | 160 | 175 | 7 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-06 | 160 | 175 | 7 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.62e-06 | 109 | 175 | 6 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-06 | 168 | 175 | 7 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 5.44e-06 | 172 | 175 | 7 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.87e-06 | 182 | 175 | 7 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.39e-06 | 187 | 175 | 7 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.39e-06 | 187 | 175 | 7 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 9.73e-06 | 188 | 175 | 7 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.73e-06 | 188 | 175 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | 18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.08e-05 | 191 | 175 | 7 | 86ce98d2c90c196474b06869de888cf5d1eed196 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 175 | 7 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-05 | 194 | 175 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 196 | 175 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.36e-05 | 198 | 175 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 199 | 175 | 7 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 6.14e-05 | 172 | 175 | 6 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 179 | 175 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 7.65e-05 | 179 | 175 | 6 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 7.65e-05 | 179 | 175 | 6 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-05 | 180 | 175 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.13e-05 | 181 | 175 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 9.17e-05 | 185 | 175 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.17e-05 | 185 | 175 | 6 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.45e-05 | 186 | 175 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.73e-05 | 187 | 175 | 6 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 188 | 175 | 6 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 188 | 175 | 6 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 188 | 175 | 6 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 189 | 175 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 1.03e-04 | 189 | 175 | 6 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 189 | 175 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 189 | 175 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 190 | 175 | 6 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 1.06e-04 | 190 | 175 | 6 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-04 | 190 | 175 | 6 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-duct_epithelial_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 190 | 175 | 6 | 5b3f773380aef4773b70f0dbd74992d28e6586c6 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 191 | 175 | 6 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 191 | 175 | 6 | 629007189034ee8451411428f1c6cc57daee2d91 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 192 | 175 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.12e-04 | 192 | 175 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 193 | 175 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.16e-04 | 193 | 175 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 193 | 175 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 193 | 175 | 6 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 193 | 175 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 194 | 175 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 194 | 175 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 1.22e-04 | 195 | 175 | 6 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 195 | 175 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 195 | 175 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 195 | 175 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 196 | 175 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.26e-04 | 196 | 175 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.26e-04 | 196 | 175 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.26e-04 | 196 | 175 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 198 | 175 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 198 | 175 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.33e-04 | 198 | 175 | 6 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-04 | 199 | 175 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 199 | 175 | 6 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 199 | 175 | 6 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-04 | 199 | 175 | 6 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.40e-04 | 200 | 175 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.40e-04 | 200 | 175 | 6 | 09deb831fc2c8a8867cc850f3aa094a5e48489ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-04 | 200 | 175 | 6 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-04 | 200 | 175 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 200 | 175 | 6 | 16a70cc07dcfb4eba4385b712f27010c6629ff67 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-04 | 128 | 175 | 5 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-04 | 128 | 175 | 5 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| Disease | carboxypeptidase Z measurement | 1.92e-04 | 4 | 168 | 2 | EFO_0801455 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.92e-04 | 4 | 168 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | epilepsy (is_marker_for) | 1.92e-04 | 4 | 168 | 2 | DOID:1826 (is_marker_for) | |
| Disease | hepatitis (biomarker_via_orthology) | 1.92e-04 | 4 | 168 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | renal hypertension (implicated_via_orthology) | 3.19e-04 | 5 | 168 | 2 | DOID:1073 (implicated_via_orthology) | |
| Disease | pleurisy (biomarker_via_orthology) | 3.19e-04 | 5 | 168 | 2 | DOID:10247 (biomarker_via_orthology) | |
| Disease | pulmonary emphysema (biomarker_via_orthology) | 4.76e-04 | 6 | 168 | 2 | DOID:9675 (biomarker_via_orthology) | |
| Disease | Retinal Diseases | 4.80e-04 | 27 | 168 | 3 | C0035309 | |
| Disease | Prostatic Neoplasms | FOLH1 NAGLU OGG1 ST14 SIRT1 ACSM3 SPON2 ALOXE3 SPOP MMP9 PML | 8.48e-04 | 616 | 168 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | FOLH1 NAGLU OGG1 ST14 SIRT1 ACSM3 SPON2 ALOXE3 SPOP MMP9 PML | 8.48e-04 | 616 | 168 | 11 | C0376358 |
| Disease | Vasogenic Brain Edema | 8.82e-04 | 8 | 168 | 2 | C0750969 | |
| Disease | Cytotoxic Brain Edema | 8.82e-04 | 8 | 168 | 2 | C0750970 | |
| Disease | Cytotoxic Cerebral Edema | 8.82e-04 | 8 | 168 | 2 | C0472388 | |
| Disease | Vasogenic Cerebral Edema | 8.82e-04 | 8 | 168 | 2 | C0472387 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 8.82e-04 | 8 | 168 | 2 | DOID:5520 (is_marker_for) | |
| Disease | Brain Edema | 8.82e-04 | 8 | 168 | 2 | C1527311 | |
| Disease | Cerebral Edema | 8.82e-04 | 8 | 168 | 2 | C0006114 | |
| Disease | Marfan Syndrome, Type I | 1.13e-03 | 9 | 168 | 2 | C4721845 | |
| Disease | egg allergy measurement | 1.13e-03 | 9 | 168 | 2 | EFO_0007018 | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 1.71e-03 | 11 | 168 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | Premature Birth | 1.71e-03 | 11 | 168 | 2 | C0151526 | |
| Disease | Marfan Syndrome | 1.71e-03 | 11 | 168 | 2 | C0024796 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 2.00e-03 | 93 | 168 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Huntington Disease, Late Onset | 2.05e-03 | 12 | 168 | 2 | C0393574 | |
| Disease | triacylglycerol 58:12 measurement | 2.05e-03 | 12 | 168 | 2 | EFO_0010439 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 2.05e-03 | 12 | 168 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 2.05e-03 | 12 | 168 | 2 | C0751208 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.05e-03 | 12 | 168 | 2 | DOID:3319 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 2.10e-03 | 157 | 168 | 5 | DOID:9256 (is_marker_for) | |
| Disease | lung disease (implicated_via_orthology) | 2.41e-03 | 13 | 168 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | plasma beta-amyloid 1-42 measurement | 2.41e-03 | 13 | 168 | 2 | EFO_0005660 | |
| Disease | survival time, breast carcinoma | 2.41e-03 | 13 | 168 | 2 | EFO_0000305, EFO_0000714 | |
| Disease | bronchiolitis obliterans (is_marker_for) | 2.41e-03 | 13 | 168 | 2 | DOID:2799 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 2.47e-03 | 163 | 168 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.60e-03 | 100 | 168 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | response to olanzapine | 3.22e-03 | 15 | 168 | 2 | GO_0097333 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 3.22e-03 | 15 | 168 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Streptozotocin Diabetes | 3.43e-03 | 108 | 168 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 3.43e-03 | 108 | 168 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 3.43e-03 | 108 | 168 | 4 | C0002152 | |
| Disease | Benign neoplasm of stomach | 4.14e-03 | 17 | 168 | 2 | C0153943 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 4.14e-03 | 17 | 168 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.14e-03 | 17 | 168 | 2 | C0496905 | |
| Disease | Huntington Disease | 4.14e-03 | 17 | 168 | 2 | C0020179 | |
| Disease | Carcinoma in situ of stomach | 4.14e-03 | 17 | 168 | 2 | C0154060 | |
| Disease | nevus count | 4.64e-03 | 18 | 168 | 2 | EFO_0004632 | |
| Disease | Gastric ulcer | 4.64e-03 | 18 | 168 | 2 | C0038358 | |
| Disease | Malignant neoplasm of endometrium | 4.64e-03 | 18 | 168 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.64e-03 | 18 | 168 | 2 | C0346191 | |
| Disease | creatinine measurement | IGF2-AS FBXL17 FBXO36 BTAF1 ADGRV1 ST14 RFWD3 FRY ACSM3 PLA2G6 ASXL2 PLEKHA7 QSOX2 | 4.70e-03 | 995 | 168 | 13 | EFO_0004518 |
| Disease | psoriasis vulgaris | 5.12e-03 | 61 | 168 | 3 | EFO_1001494 | |
| Disease | cutaneous melanoma | 5.14e-03 | 121 | 168 | 4 | EFO_0000389 | |
| Disease | Abnormality of refraction | SMG1 ANK3 GPR78 FRY ARL6IP6 PHACTR3 PLA2G6 PEAK1 QSOX2 TBL1X | 5.37e-03 | 673 | 168 | 10 | HP_0000539 |
| Disease | amino acid measurement | TANC2 FOLH1 COG7 TMEM114 GPR162 DNAH7 MLYCD SETD7 HRH3 IL27RA | 5.65e-03 | 678 | 168 | 10 | EFO_0005134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALSLHDWIASQFSGR | 431 | P60509 | |
| ADQLCLDRWFTLSSG | 886 | Q9BSJ8 | |
| AASRDLDWEVRAQGL | 641 | Q6PJG6 | |
| LRQAFGDDWGSILSF | 186 | Q7Z695 | |
| FDVKEWINAAFRAGS | 11 | P83436 | |
| WINAAFRAGSKEAAS | 16 | P83436 | |
| DTWALGNSETEKAFR | 116 | Q8NEF3 | |
| LRFSWAQGTDTILAD | 711 | Q8TDI0 | |
| NAEFWLSLDDQVSGL | 191 | Q6L9W6 | |
| VDRDIQLLCQSSGWF | 146 | Q6UX41 | |
| LCVGDQAQDWRSSLF | 51 | Q9BYD9 | |
| ELQARSNIWVAGDAA | 426 | O95831 | |
| AEAARQASASRAWGL | 291 | P22570 | |
| SDADSQAIWGLADQL | 5621 | Q8WXG9 | |
| AASEPRALDWVASAN | 956 | C9J069 | |
| FGSRLGVAARVWDAA | 46 | Q96AZ1 | |
| CAFADSLSEDLWLRA | 246 | Q5JTW2 | |
| RFILLEGSQLDASDW | 426 | O14525 | |
| LQLSGVSLFWDEFSA | 221 | Q96BY7 | |
| FFTSAAQGWKERLSE | 331 | Q76L83 | |
| ASDSRFLLGSWLEQA | 611 | P54802 | |
| FLLGSWLEQARAAAV | 616 | P54802 | |
| LAASADLRGGFDWSL | 251 | Q8N428 | |
| DSFAVSAAWARKGIE | 21 | Q969G9 | |
| DDTWIERGQVFSALS | 1461 | Q6ZS30 | |
| DDTILSSALAANGWV | 241 | Q8NFJ5 | |
| LSVEDGAFVASARQW | 231 | Q9UBG7 | |
| GAFVASARQWAAFTL | 236 | Q9UBG7 | |
| SARQWAAFTLHLADG | 241 | Q9UBG7 | |
| FADILSGDWNTRSLL | 476 | O75943 | |
| GDVRDWASAIRVAAL | 106 | Q6ZRP7 | |
| EAANSALLWDAASGS | 721 | Q6PCD5 | |
| VFDGWDISSLNLAEA | 136 | Q9NPH2 | |
| IDAASPFWEASRRAL | 251 | Q92806 | |
| DGRTILVDFWDTAGQ | 66 | Q9UNT1 | |
| ELSGQEDAFRSWAVQ | 661 | P35228 | |
| VIDDAFARAFALWSA | 136 | P14780 | |
| DASANEILGSLRWRD | 2711 | Q9NU22 | |
| FIGDAATANNRFELW | 46 | Q6B8I1 | |
| FADVLSRLALWESEG | 311 | Q8TD91 | |
| RFASSGDDIKIWDAS | 6 | Q8NHV4 | |
| DWSIEAAVATFAQAR | 146 | O60942 | |
| LAGDSLFWSEADVVQ | 191 | O43187 | |
| AGAEEASLRSNALSW | 6 | Q16538 | |
| ALQRAAWGISETESD | 1011 | Q9NS40 | |
| QALGWDELAARVTAL | 651 | Q9H8L6 | |
| SLALSDRGQLFSWGA | 96 | Q15034 | |
| WTGEIFAQAFLGRES | 546 | Q9BYJ1 | |
| TDWIGFAVAQRLAQD | 41 | P0CG22 | |
| FGLLGSTEWAEENSR | 426 | Q04609 | |
| GNRAGWFLDRIDITD | 891 | Q8IVV2 | |
| LSEWFSSGFLNLERV | 186 | O95822 | |
| NGALTEALARWEAAA | 136 | A0A1B0GVG4 | |
| LSQALREAEADGAAW | 191 | Q8N8D1 | |
| WTLEGRAAQDSSRSF | 41 | Q96T54 | |
| WLDGNSLCDTFRDQS | 321 | Q9UBU9 | |
| QLRFGVDSWSDFRLT | 1316 | Q9H792 | |
| FASASGDQTLRIWDV | 171 | O00628 | |
| SGEIWARFLAFESNI | 481 | Q12996 | |
| ALAEDTGWRQLFFTN | 151 | Q8NEA4 | |
| WVRAQLLGEGFADES | 861 | Q9H6R4 | |
| NIFASSSDDGRVLIW | 156 | Q96JK2 | |
| LASASSVWGFREELA | 401 | Q6UWB1 | |
| ADLSAETLQARREWG | 251 | Q9UN81 | |
| SSSLQDFDIRAILDW | 1116 | Q07864 | |
| AGWAQAVLFSADLRQ | 311 | O15527 | |
| FLESAGWDLQIALAS | 26 | Q9UNZ2 | |
| SVAALSADQWLAVGF | 96 | Q96P69 | |
| QQEAWFALDLGLDSS | 101 | Q86X67 | |
| DWSSADNVLDGASLV | 486 | Q969R2 | |
| GRFQDSWRLSDGFVA | 356 | Q6R327 | |
| SWRLSDGFVAAEAKT | 361 | Q6R327 | |
| NRALEARDASGFWSS | 451 | Q86VI3 | |
| VLAAGTDFRSDRLWE | 196 | Q86UA1 | |
| AAVVTAGEAELNWSR | 6 | Q96CX6 | |
| SWNLLGDEAAAELAQ | 1776 | Q86WI3 | |
| AAAALAWLAVGTTAA | 51 | A8CG34 | |
| ELAWGVARDTAEFAA | 151 | O60240 | |
| ALAESWNAAFLESSA | 136 | Q15382 | |
| AIQVRGLADSGWFLD | 256 | Q6P988 | |
| SRDAWQDLAGCDFVL | 696 | Q96JP2 | |
| LSVNDAFVTGEWGRA | 126 | P30044 | |
| TVSDLALQNAFGDRW | 751 | Q7Z3G6 | |
| AAAALAWLTVGATAA | 51 | Q96HA1 | |
| FSEAQAAAWLEAARG | 136 | Q86VR8 | |
| ALAWNAEQLSSGSRD | 276 | Q9UM11 | |
| RAVDSAEARAWALGQ | 131 | Q9BW83 | |
| GSERSNALWQAVDAA | 86 | Q6U949 | |
| AESWARLAQVVDDGA | 871 | Q86XA9 | |
| WSTSDQFLDLLAGDE | 1351 | Q9P2K1 | |
| LSFASSQRDLFEDGW | 596 | Q9Y6J0 | |
| GEAQWLALVSLFVAA | 11 | Q9Y426 | |
| AWAARTLFKDASGNL | 526 | Q9BZ29 | |
| DAAWVSVANRGQFAS | 486 | Q8WTW3 | |
| LRSANWDTRIAAGQA | 51 | O14981 | |
| LFGRRWAIASDDLVF | 6 | Q8NCG7 | |
| LAAAAAWEQQGRSLF | 146 | Q9UF56 | |
| WSDGVLAVSFRAFAS | 1666 | Q8WXX0 | |
| GDKSRAWVAAAEESL | 76 | Q8IYS4 | |
| TLASDLQDWASVGAF | 406 | Q92949 | |
| LGLSWTELARELNFS | 4101 | Q12955 | |
| LLLTDNEAWNGFVAA | 86 | O14791 | |
| ARGFSAAWTAVLAAL | 26 | Q9Y5N1 | |
| EALARGDNFETVTWL | 106 | Q68D91 | |
| ADGWTDVNSALLAAA | 356 | Q6UXX5 | |
| TASLDEWTAGARAAF | 701 | O75578 | |
| FKNATEAAWRALASG | 36 | P20933 | |
| GARQLESAAAEQWVS | 431 | Q76NI1 | |
| LFISASNDGTARIWD | 1701 | Q6ZMW3 | |
| NSLQGLLVDFSDWRE | 646 | Q5TBA9 | |
| NAARWAAGSVTDLAF | 636 | Q8WUI4 | |
| REANDAVLFGFLTTW | 146 | P13807 | |
| QLDSLWLLDSDGSFT | 441 | P54803 | |
| RALRLDVGNFSWGSE | 56 | P62241 | |
| FLAVNTWGRAIFDLD | 541 | Q86YT5 | |
| EFGWRNVFLLSAAVN | 456 | Q9Y2C5 | |
| SRLSTGASADAVWDN | 501 | Q96LW4 | |
| SVIRWAGSDFQDIAL | 236 | Q93086 | |
| RALELFDWLGAVFSN | 236 | O75818 | |
| EAWSFDGALENKRTA | 341 | Q96KR7 | |
| RGALQEELARSFFWQ | 136 | P11309 | |
| DNTANFLSWCRDLGV | 111 | O43903 | |
| WNLGADAGSRLTDVF | 36 | A2RUB1 | |
| VGELWDRFQTRSFLA | 291 | A4D263 | |
| LSGAVEQWLSAAERL | 291 | Q9HAU8 | |
| WEDFSQSLARGNSEL | 146 | Q8IYL2 | |
| SNGLRDFAERGEAWA | 91 | Q9BUD6 | |
| IWDAFTGELRASFRA | 256 | Q9BUR4 | |
| ERLLSNGWETASAVD | 266 | Q9UIC8 | |
| AEDLSLGVEWLSRFG | 46 | Q9ULZ9 | |
| RLWEFQEAISGFLAA | 696 | P29590 | |
| EQLVDLTSRDGAWFL | 2791 | Q96Q15 | |
| FATWLLEAQAATGFL | 1926 | P58107 | |
| DLWRIEDVTAGLSAN | 811 | Q6IQ23 | |
| DSRDWALNGNTLSLD | 256 | Q8WTS6 | |
| ASQRLAASITWADGE | 561 | Q13796 | |
| AAAALWREAEAEAAA | 71 | Q96EB6 | |
| RFAGLNVAWLESSEA | 26 | Q96T21 | |
| VDSARAVDFGLSILW | 176 | O15126 | |
| VERAQINSFDSLWGE | 1021 | Q9HCD6 | |
| SIGSQWARAEDALQA | 1021 | Q6ZUB1 | |
| SDQLVWRAARSSGAA | 626 | O60733 | |
| AFWALTQLLAGERHS | 206 | Q86UD7 | |
| DADARAVALAGSTNW | 21 | Q6PJ21 | |
| ASLSFAESWDNVGLL | 41 | Q9GZT8 | |
| VDDAGLLSFATFSWL | 46 | Q96J65 | |
| LALLRTFDAGEFTGW | 11 | P57078 | |
| TATDDGAIRVWKNFA | 1086 | Q8N122 | |
| AGLEWAEAARSQALQ | 401 | Q9NRC6 | |
| QFSRDASVAEAWLLG | 2021 | Q01082 | |
| FWFVARADDVILSSG | 471 | Q53FZ2 | |
| VARDLRAEFSAGAWS | 51 | Q8N6S5 | |
| VAVQDFAGSWRSGLA | 206 | Q96JQ2 | |
| AWLAEAESRVLSNRG | 466 | Q15642 | |
| LSIFLAWDVDIGSDN | 86 | A8MTZ7 | |
| AFSLGATLWINSEEF | 1391 | Q7KZ85 | |
| FARIWTEDGNLASTL | 311 | O60907 | |
| SGEWRSEEQLFRSAL | 461 | Q5T4D3 | |
| AALAWFSRPAAAEEE | 61 | Q6DKK2 | |
| LVASAGLDRQIFLWD | 131 | Q8TAF3 | |
| GLERNDSWGSFDLRA | 646 | Q7Z417 | |
| AEAWAQLQGSSAARR | 1886 | O15020 | |
| LSWARTLELGADFSQ | 311 | Q8N271 | |
| LRTAGAAASLSEAWL | 36 | Q14159 | |
| LAEDLGNLWENTRFT | 186 | Q6IQ16 | |
| LADELGGLWENSRFT | 186 | O43791 | |
| LSDATFSDIRREGWL | 681 | Q9P227 | |
| WALRGDADSVLSLTF | 246 | Q9Y5Y6 | |
| DLRQFWVAEGGTISD | 16 | Q8NHR7 | |
| ALATALDVGLSNWSF | 91 | Q9NQQ7 | |
| ALLDQVDISFGWSLA | 176 | B3SHH9 | |
| LFAAGVWLARNLSDI | 51 | Q96B49 | |
| ELLRSVNDFLWLGAA | 231 | Q96Q05 | |
| RWSIGKAIDFAASLA | 186 | Q8TCF1 | |
| VANRLASDGATWADI | 351 | Q8NHP8 | |
| ASDGATWADIFKRFN | 356 | Q8NHP8 | |
| WRNLTGFTDEQLGDL | 656 | Q92508 | |
| GFFTLDSALLRTQWD | 261 | O95900 | |
| DCRISNNFTGLEWDL | 116 | Q9H497 | |
| IFWALNEGVSRQFDS | 1826 | Q14669 | |
| GVIDDAFALWLQDST | 751 | Q69YN4 | |
| RWLDGASFDNERGST | 321 | O95071 | |
| GFLALDVAANRLWVT | 96 | Q8IYS2 | |
| LRAAEDAVWSGATFI | 216 | Q9Y303 | |
| AESIQWFRDGSLLRS | 301 | Q5VTT5 |